- Losing weight is hard. For many people, diets and exercise don’t work in the long term. Genetics can also play a role in people’s body weight (and their ability to lose it).
- In this month’s episode of Bhekisisa’s television show, Health Beat, they speak to two people who’ve used the weight loss drug, Semaglutide (in the form of the diabetes injection, Ozempic, as the weight loss version, Wegovy, is not yet registered in South Africa).
- Mia Malan asks an endocrinologist how the medicine works, who should get it, how much it costs and what the side effects are. Malan also speaks to the public health specialist, Susan Goldstein of the health project, Priceless SA, about why products that make us fat — processed foods — need to be better regulated.
Mia Malan is the founder and editor-in-chief of Bhekisisa. She has worked in newsrooms in Johannesburg, Nairobi and Washington, DC, winning more than 30 awards for her radio, print and television work.
Mohale Moloi worked at Bhekisisa as a television producer and health journalist from July 2021 to March 2024.
Jessica Pitchford is Bhekisisa's TV and multimedia editor. She's been a journalist since the early nineties and has reported on some pivotal events in South Africa’s political history, such as the country’s transition to democracy and the work of the Truth & Reconciliation Commission.
. In this month’s episode of our television show, Health Beat, we speak to two people who've used the weight loss drug, semaglutide.){kind=link}